{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:49:00Z","timestamp":1775022540263,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jphs.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T21:57:07Z","timestamp":1660946227000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation of DNA-aptamers targeting galectin-7 for the identification of cholesteatoma residue"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-7317","authenticated-orcid":false,"given":"Shuang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Takemasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarsanaa","family":"Javkhlant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Hato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2022.08.002_bib1","series-title":"Middle ear cholesteatoma. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2021","author":"Kennedy","year":"2021"},{"issue":"7","key":"10.1016\/j.jphs.2022.08.002_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/MAO.0000000000003150","article-title":"Evaluation of long-term cholesteatoma recidivism: using the JOS, EAONO-JOS, and STAMCO cholesteatoma staging systems","volume":"42","author":"Eggink","year":"2021","journal-title":"Otol Neurotol"},{"issue":"4","key":"10.1016\/j.jphs.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"E220","DOI":"10.1002\/lary.28084","article-title":"Perimatrix of middle ear cholesteatoma: a granulation tissue with a specific transcriptomic signature","volume":"130","author":"Jovanovic","year":"2020","journal-title":"Laryngoscope"},{"issue":"Suppl S5","key":"10.1016\/j.jphs.2022.08.002_bib4","first-page":"S1","article-title":"Differential gene expression in cholesteatoma by DNA chip analysis","volume":"123","author":"Macias","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jphs.2022.08.002_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5631\/jibirin.104.625","article-title":"Expression of Galectin-7 in cholesteatoma matrix and its clinical significance","volume":"104","author":"Takagi","year":"2011","journal-title":"Practica oto-rhino-laryngologica"},{"issue":"3","key":"10.1016\/j.jphs.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MAO.0b013e3182488021","article-title":"Galectin-7 as a marker of cholesteatoma residue and its detection during surgery by an immunofluorescent method--a preliminary study","volume":"33","author":"Takagi","year":"2012","journal-title":"Otol Neurotol"},{"issue":"11","key":"10.1016\/j.jphs.2022.08.002_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111720","article-title":"Functions and inhibition of galectin-7, an emerging target in cellular pathophysiology","volume":"11","author":"Sewgobind","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jphs.2022.08.002_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4939-8802-0_11","article-title":"Generation of specific aptamers","volume":"1868","author":"Liu","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jphs.2022.08.002_bib9","first-page":"7510214","article-title":"Genetic manipulation of calcium release-activated calcium channel 1 modulates the multipotency of human cartilage-derived mesenchymal stem cells","volume":"2019","author":"Liu","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jphs.2022.08.002_bib10","doi-asserted-by":"crossref","first-page":"107872","DOI":"10.1016\/j.jmgm.2021.107872","article-title":"In silico approach for Post-SELEX DNA aptamers: a mini-review","volume":"105","author":"Ahmad","year":"2021","journal-title":"J\u00a0Mol Graph Model"},{"issue":"W1","key":"10.1016\/j.jphs.2022.08.002_bib11","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jphs.2022.08.002_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.jphs.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s11095-004-7676-4","article-title":"Pharmacokinetics and biodistribution of novel aptamer compositions","volume":"21","author":"Healy","year":"2004","journal-title":"Pharm Res (N Y)"},{"issue":"1","key":"10.1016\/j.jphs.2022.08.002_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25010003","article-title":"Aptamers chemistry: chemical modifications and conjugation strategies","volume":"25","author":"Odeh","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jphs.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1872210513666181128162403","article-title":"Biodistribution, safety and organ toxicity of docetaxel-loaded in HER-2 aptamer conjugated Ecoflex\u00ae nanoparticles in a mouse xenograft model of ovarian cancer","volume":"13","author":"Ghassami","year":"2019","journal-title":"Recent Pat Nanotechnol"},{"issue":"23","key":"10.1016\/j.jphs.2022.08.002_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234229","article-title":"Aptamers: a review of their chemical properties and modifications for therapeutic application","volume":"24","author":"Adachi","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jphs.2022.08.002_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ph11030062","article-title":"Potential inherent stimulation of the innate immune system by nucleic acid aptamers and possible corrective approaches","volume":"11","author":"Bruno","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jphs.2022.08.002_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2407-10-290","article-title":"Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis","volume":"10","author":"Zhu","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jphs.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.2353\/ajpath.2010.090876","article-title":"Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells","volume":"176","author":"Demers","year":"2010","journal-title":"Am J Pathol"},{"issue":"17","key":"10.1016\/j.jphs.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.18632\/oncotarget.2299","article-title":"Expression and functions of galectin-7 in ovarian cancer","volume":"5","author":"Labrie","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jphs.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3389\/fchem.2020.00593","article-title":"Targeting galectins with glycomimetics","volume":"8","author":"Bertuzzi","year":"2020","journal-title":"Front Chem"},{"issue":"3","key":"10.1016\/j.jphs.2022.08.002_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BCJ20200167","article-title":"Reprogramming the tumor metastasis cascade by targeting galectin-driven networks","volume":"478","author":"Perrotta","year":"2021","journal-title":"Biochem J"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:07Z","timestamp":1761163327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861322000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1347861322000627"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2022.08.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of DNA-aptamers targeting galectin-7 for the identification of cholesteatoma residue","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}